Daniel J. Sajkowski, serving as a director at Calumet, Inc. (NASDAQ: CLMT), has completed a transaction involving the sale of 4,240 shares of the company's common stock. The execution of this sale took place on July 1, 2026, resulting in a total transaction value of $153,318.
The shares were sold at prices fluctuating between $35.72 and $36.33 per share. Calculating the weighted average across these transactions yields a sale price of $36.16 per share. This execution was carried out under the guidelines of a Rule 10b5-1 trading plan. Mr. Sajkowski established this pre-arranged plan on November 18, 2025.
At the time the trading plan was adopted, Calumet's common stock closed at $19.08 per share on the Nasdaq Global Select Market. Since that November date, the stock has experienced a significant appreciation, surging 123% over the past year according to InvestingPro data. The equity is currently trading near its 52-week high of $38.75.
Following the completion of these transactions, Mr. Sajkowski's direct ownership of Calumet, Inc. common stock stands at 77,718 shares. Market analysis from InvestingPro indicates that the stock is currently overvalued relative to its Fair Value estimate.
This insider activity coincides with recent financial reporting from Calumet Inc. The company reported financial results for the first quarter of 2026, which revealed a notable miss on earnings expectations. The reported earnings per share (EPS) stood at -$3.64. This figure was significantly below the anticipated EPS of -$0.31.
Despite the shortfall in earnings, Calumet's revenue performance slightly exceeded market forecasts. The company reported revenue of $1.03 billion, surpassing the forecasted $1.01 billion. These financial developments have generated reactions within the market, reflecting investor concerns regarding the company's financial performance. The divergence between earnings misses and revenue beats highlights challenges in aligning financial outcomes with market forecasts.